Danuglipron for Glycemic Control Among Patients With Type 2 DiabetesThis randomized clinical trial investigates the efficacy, safety, and tolerability of danuglipron treatment for 16 weeks in adults with type 2 diabetes and inadequate glycemic control on diet and exercise, with or without the use of metformin.https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2805054Could Danuglipron Be the Next Ozempic in Pill Form?Danuglipron, a new drug from Pfizer, could be the next blockbuster diabetes and weight loss drug, after competitors Ozempic, Wegovy, and Mounjaro.https://www.everydayhealth.com/diabetes/could-this-pill-be-the-next-ozempic/Pfizer scraps one weight loss drug in race to develop Ozempic rivalPfizer Inc said it is scrapping its once-a-day experimental obesity pill because of concerns about liver safety, but will continue developing its other obesity pill, the twice daily treatment danuglipron, as it races to rival the success of other weight loss treatments.https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-discontinue-development-obesity-drug-2023-06-26/
Seonglae ChoSeonglae ChoSeonglae ChoSeonglae ChoSeonglae ChoSeonglae Cho
%2Fcloudfront-us-east-2.images.arcpublishing.com%2Freuters%2FLQ6XXTJXGZNHNHONNLIUUZR3EU.jpg?table=block&id=1c0318db-5fa6-4d32-9faa-738547900a73&cache=v2)